Compugen Ltd. (CGEN)
NASDAQ·Healthcare·Biotechnology
$2.03
-0.74%
Mkt Cap $198.56M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$4.50
Range $4.00 – $5.00
Implied Upside
+122.2%
Consensus $4.50 vs current $2.03
NASDAQ·Healthcare·Biotechnology
$2.03
-0.74%
Mkt Cap $198.56M
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$4.50
Range $4.00 – $5.00
+122.2%
Consensus $4.50 vs current $2.03